Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001570433 | SCV001794725 | uncertain significance | not provided | 2020-01-15 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Identified by a next-generation sequencing panel in a proband with sporadic congenital mild-to-moderate bilateral hearing loss in published literature (Sloan-Heggen et al., 2016) who also harbored a missense variant in TECTA, the phase of which was unknown; This variant is associated with the following publications: (PMID: 26969326) |
Labcorp Genetics |
RCV001570433 | SCV003440424 | pathogenic | not provided | 2022-03-24 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1204164). This sequence change creates a premature translational stop signal (p.Ile1556Serfs*9) in the TECTA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TECTA are known to be pathogenic (PMID: 11087000, 12746400, 17431902, 24130743). This variant is present in population databases (rs764570434, gnomAD 0.0008%). This premature translational stop signal has been observed in individual(s) with autosomal recessive deafness (PMID: 26969326). |